Anders Hviid
- Health top 0.5%
- Vaccine Coverage and Hesitancy 22
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research 25
- COVID-19 Clinical Research Studies 13
- Epidemiology top 1%
- Influenza Virus Research Studies 13
- Microbiology top 1%
- Bacterial Infections and Vaccines 11
- Obstetrics and Gynecology top 2%
-
- Long-Term Effects of COVID-19 13
-
- Pregnancy and Medication Impact 11
-
- Heparin-Induced Thrombocytopenia and Thrombosis 11
- Co-authors
- Henrik SvanströmBjörn PasternakMads MelbyeDitte Mølgaard‐NielsenMorten FrischJan WohlfahrtKathrin MühlemannSteven A. Rubin
- Partner nations
- DenmarkSwedenUnited States
In The Last Decade
Anders Hviid
144 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 152
- Health 1.2k
- Infectious Diseases 1.5k
- Epidemiology 2.4k
- Microbiology 410
- Obstetrics and Gynecology 318
Countries citing papers authored by Anders Hviid
This map shows the geographic impact of Anders Hviid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Hviid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Hviid more than expected).
Fields of papers citing papers by Anders Hviid
This network shows the impact of papers produced by Anders Hviid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Hviid. The network helps show where Anders Hviid may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anders Hviid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 7 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 20 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 16 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 9 | |
| 15 | 2023 | 18 | |
| 16 | 2022 | 53 | |
| 17 | 2021 | 21 | |
| 18 | 2020 | 34 | |
| 19 | 2017 | 62 | |
| 20 | 2003 | 41 |
About Anders Hviid
Anders Hviid is a scholar working on Health, Infectious Diseases, Microbiology, Epidemiology and Obstetrics and Gynecology, having authored 159 papers that have together received 6.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (25 papers), Vaccine Coverage and Hesitancy (22 papers), Influenza Virus Research Studies (13 papers), Long-Term Effects of COVID-19 (13 papers), COVID-19 Clinical Research Studies (13 papers), Pregnancy and Medication Impact (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (11 papers) and Bacterial Infections and Vaccines (11 papers). The work is most often cited by research in Health (1.2k citations), Infectious Diseases (1.5k citations), Epidemiology (2.4k citations), Microbiology (410 citations) and Obstetrics and Gynecology (318 citations). Anders Hviid has collaborated with scholars based in Denmark, Sweden and United States. Frequent co-authors include Henrik Svanström, Björn Pasternak, Mads Melbye, Ditte Mølgaard‐Nielsen, Morten Frisch, Jan Wohlfahrt, Kathrin Mühlemann, Steven A. Rubin, Mogens Vestergaard and Jørgen Vinsløv Hansen. Their work appears in journals such as JAMA, BMJ, New England Journal of Medicine, Vaccine and American Journal of Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.